Floatz logo

Therapeutic Asset Ratings

123 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Blinatumomab
Leukemia
Dana-Farber Cancer InstituteP2CCC (52)
Pirtobrutinib
Leukemia
Inhye AhnP2CCC (52)
Ponatinib
Leukemia
M.D. Anderson Cancer CenterP2CCC (52)
Therapeutic Autologous Lymphocytes
Leukemia
Memorial Sloan Kettering Cancer CenterP1/2CCC (52)
Lactobacillus Plantarum Strain 299V
Leukemia
Children's Oncology GroupP3CCC (51)
Tocilizumab
Leukemia
Insel Gruppe AG, University Hospital BernP2CCC (51)
Valaciclovir
Leukemia
M.D. Anderson Cancer CenterP2CCC (51)
Amoxicillin
Leukemia
Monash UniversityP2/3CCC (50)
CLAVULANIC ACID
Leukemia
Monash UniversityP2/3CCC (50)
SULFAMETHOXAZOLE
Leukemia
Monash UniversityP2/3CCC (50)
Trimethoprim
Leukemia
Monash UniversityP2/3CCC (50)
Revumenib
Leukemia
Memorial Sloan Kettering Cancer CenterP1/2CCC (49)
Tisagenlecleucel
Leukemia
Stanford UniversityP1/2CCC (49)
Zanubrutinib
Leukemia
Inhye AhnP1/2CCC (49)
Degarelix
Leukemia
Memorial Sloan Kettering Cancer CenterP2CCC (48)
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME (HUMAN) CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBOD
Leukemia
Imperial College Healthcare NHS TrustP2CCC (48)
LEUPROLIDE
Leukemia
Memorial Sloan Kettering Cancer CenterP2CCC (48)
OGALVIBART
Leukemia
Imperial College Healthcare NHS TrustP2CCC (48)
Sonrotoclax
Leukemia
BeiGeneP2CCC (48)
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1
Leukemia
GeoVax, Inc.P2CCC (48)
Anti-Cd30-Car-Transduced T Cells
Leukemia
Affiliated Hospital of Nantong UniversityP1/2CC (46)
IM19 CAR-T cells
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd.P1/2CC (46)
Devimistat
Leukemia
Memorial Sloan Kettering Cancer CenterP2CC (44)
Enasidenib
Leukemia
Tian Yi ZhangP1/2CC (44)
Rimiducid
Leukemia
Bellicum PharmaceuticalsP1/2CC (42)
Showing 51 to 75 of 123 assets
PreviousPage 3 of 5Next